Skip to main content
. 2019 Feb 19;19(4):3087–3094. doi: 10.3892/mmr.2019.9968

Figure 3.

Figure 3.

The expression levels of PADI4 in vitro and knockdown of PADI4 in A549 cells. (A) The statistical analysis represents the mRNA expression level of PADI4 in different lung cancer cells and normal lung epithelial cells. (B) The representative bands of western blotting and the statistical analysis. Differences among groups were analyzed by one-way ANOVA, followed by Bonferroni's multiple comparison test. *P<0.05 or **P<0.01 vs. BEAS-2B, #P<0.05 vs. H1299, n=3. (C) The efficiency of PADI4 knockdown by shRNA was confirmed by reverse transcription-quantitative polymerase chain reaction. (D) The efficiency of PADI4 knockdown by shRNA was confirmed by western blotting. Differences among groups were analyzed by one-way ANOVA, followed by Bonferroni's multiple comparison test. **P<0.01 vs. Ctrl, n=3. Ctrl, control; NC, negative control; sh, short hairpin; PADI4, protein-arginine deiminase type-4; ANOVA, analysis of variance.